EFIL – RETURN TO LIFE DRUG ELUTING STENT

EFIL – return to life® reunites the performance of Sirolimus drug with long-term advantages of a safe biodegradable polymer based drug delivery matrix released from a thin strut Co-Cr stent system.

SPECIFICATIONS

  • Hybrid and flexible stent design.
  • Thin strut cobalt chromium stent with surface modification for better drug delivery.
  • Uniform drug coating on abluminal surface using patented stent coating technology for drug release only to targeted tissue.
  • Highly safe biodegradable polymer matrix.
  • Protective top coat ensures better polymer-drug binding with negligible polymer flaking during stent expansion.
  • Biodegradable polymer matrix completely degrades in 6 – 9 months leaving behind bare metal stent.

SIZES

 

Currently not available in Europe, product under certification process.